CN(C)c1ccc(/C=C/C=C\c2cc(/C=C/C=C/c3ccc(N(C)C)cc3)[s+]c3ccccc23)cc1.[O-][Cl+3]([O-])([O-])[O-]
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?